Loading clinical trials...
Loading clinical trials...
Individually Targeted Neuromodulation for Contamination-based Obsessive-compulsive Disorder
Conditions
Interventions
cTBS
iTBS
+1 more
Locations
1
United States
McLean Hospital
Belmont, Massachusetts, United States
Start Date
July 1, 2022
Primary Completion Date
June 30, 2024
Completion Date
June 30, 2024
Last Updated
March 15, 2024
NCT06647589
NCT06804525
NCT04480918
NCT05467683
NCT03918577
NCT05623306
Lead Sponsor
Mclean Hospital
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions